Compare
Yupelri vs. Brovana

Yupelri (revefenacin) is an inhalation solution that's used to treat adults with chronic obstructive pulmonary disease (COPD). It belongs to the drug class called long-acting muscarinic antagonists, or LAMAs. Yupelri (revefenacin) is inhaled through the mouth once a day using a nebulizer machine. Some possible side effects include headache and cough. Yupelri (revefenacin) is a brand-name medication; there's currently no generic version available.

• Chronic obstructive pulmonary disease (COPD)

• Cough (4%)
• Symptoms of a common cold (4%)
• Upper respiratory tract infection (4%)
• Headache (4%)
• Back pain (2%)

• Sudden trouble breathing
• Eye problems
• Problems with urination
• Allergic reactions

Arformoterol (Brovana) is a medication that can help people with chronic obstructive pulmonary disease (COPD) breathe easier. You breathe in the medication twice per day using a nebulizer. Studies show that arformoterol (Brovana) can help your lungs work better and lower the risk of hospitalizations due to worsening COPD symptoms.

• Chronic obstructive pulmonary disease (COPD)

• General pain (8%)
• Chest pain (7%)
• Back pain (6%)
• Diarrhea (6%)
• Sinus infection (5%)
• Leg cramps (4%)
• Shortness of breath (4%)
• Rash (4%)
• Flu-like symptoms (3%)
• Swelling in arms, legs, or feet (3%)
• Chest congestion (2%)

• Not for use in people with asthma
• Narrowing of your airways (bronchospasm)
• Heart problems
• Allergic reactions